✦ LIBER ✦

Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine

✍ Scribed by Noguchi, Masanori; Sasada, Tetsuro; Itoh, Kyogo

Book ID: 120652338
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 372 KB
Volume: 62
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-012-1379-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Personalized peptide vaccines: A new the

Personalized peptide vaccines: A new therapeutic modality for cancer

✍ Kyogo Itoh; Akira Yamada 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 678 KB

Personalized peptide vaccination: A nove

Personalized peptide vaccination: A novel immunotherapeutic approach for advanced cancer

✍ Sasada, Tetsuro; Noguchi, Masanori; Yamada, Akira; Itoh, Kyogo 📂 Article 📅 2012 🏛 Informa UK (Taylor & Francis) 🌐 English ⚖ 890 KB

Next-generation peptide vaccines for adv

Next-generation peptide vaccines for advanced cancer

✍ Yamada, Akira; Sasada, Tetsuro; Noguchi, Masanori; Itoh, Kyogo 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 827 KB

Overview of therapeutic vaccination appr

Overview of therapeutic vaccination approaches for cancer

✍ Neil Berinstein 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 316 KB

Peptide vaccination – a novel therapeuti

Peptide vaccination – a novel therapeutically option for cancer patients

✍ Jinfei Chen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Oncolytic virotherapy as a personalized

Oncolytic virotherapy as a personalized cancer vaccine

✍ Qi-Xiang Li; Guohong Liu; Flossie Wong-Staal 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 149 KB

## Abstract Oncolytic virotherapy has demonstrated multimodal antitumor mechanisms in both preclinical and clinical settings for cancer treatment, including antitumor immunity. Compared with conventional immunotherapy, oncolytic viruses have the advantages of simultaneous cytoreduction and conferri